首页> 外文期刊>Archives of Endocrinology and Metabolism >Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study
【24h】

Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study

机译:巴西单中心研究表明,肾移植术后新发糖尿病的危险因素(NODAT)

获取原文
       

摘要

Objectives: This study aims to verify the new-onset diabetes after kidney transplant (NODAT) incidence in recipients within 1 year after kidney transplantation from a single center in Southern Brazil and to assess the associated conditions. Subjects and methods: A retrospective study of 258 post-renal transplant patients was performed. Demographic (gender, age, ethnic background) and clinical (origin of graft, associated infections, body mass index (BMI) at transplant time and 6 and 12 months after, causes of renal failure, and comorbidities) data were analyzed. All patients were on tacrolimus, mycophenolate mofetil, and prednisone treatment. Patients with and without NODAT were compared. Results: A NODAT incidence of 31.2% was noted 1 year post transplantation. In the univariate analysis, patients with NODAT were older (p = 0.001), mostly had African–American ethnic background (p = 0.02), and had renal failure secondary to high blood pressure (HBP) (p = 0.001). The group of patients with NODAT also had more incidence of post-transplant HBP (p = 0.01), heart failure (p = 0.02), and dyslipidemia (p = 0.001). Logistic regression showed that African–American ethnic background, post-transplant HBP, and dyslipidemia were independently associated with NODAT. Conclusion: This study shows a NODAT incidence that is greater in patients with African–American ethnic background and that is associated with HBP and dyslipidemia.
机译:目的:本研究旨在验证来自巴西南部一个中心的肾脏移植术后1年内接受肾移植的新发糖尿病(NODAT)的发病率,并评估相关状况。对象和方法:回顾性研究了258名肾移植术后患者。分析了人口统计学(性别,年龄,种族背景)和临床(移植起源,相关感染,移植时以及术后6和12个月的体重指数(BMI),肾衰竭的原因和合并症)数据。所有患者均接受他克莫司,霉酚酸酯和泼尼松治疗。比较有无NODAT的患者。结果:移植后1年NODAT发生率为31.2%。在单变量分析中,NODAT患者年龄较大(p = 0.001),大多数有非裔美国人背景(p = 0.02),并且患有继发于高血压(HBP)的肾衰竭(p = 0.001)。 NODAT患者组的移植后HBP(p = 0.01),心力衰竭(p = 0.02)和血脂异常(p = 0.001)的发生率也更高。 Logistic回归显示,非裔美国人种族背景,移植后HBP和血脂异常与NODAT独立相关。结论:这项研究表明,具有非裔美国人背景的患者的NODAT发病率更高,并且与HBP和血脂异常有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号